96 related articles for article (PubMed ID: 7304194)
1. The fate of p-bromo-methylamphetamine (V-111) in the body.
Magyar K; Tekes K; Zólyomi G; Szüts T; Knoll J
Acta Physiol Acad Sci Hung; 1981; 57(3):285-307. PubMed ID: 7304194
[TBL] [Abstract][Full Text] [Related]
2. Designer drugs 2,5-dimethoxy-4-bromo-amphetamine (DOB) and 2,5-dimethoxy-4-bromo-methamphetamine (MDOB): studies on their metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques.
Ewald AH; Fritschi G; Bork WR; Maurer HH
J Mass Spectrom; 2006 Apr; 41(4):487-98. PubMed ID: 16470568
[TBL] [Abstract][Full Text] [Related]
3. A study of the metabolism of methamphetamine and 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in isolated rat hepatocytes.
Kanamori T; Tsujikawa K; Ohmae Y; Iwata YT; Inoue H; Kishi T; Nakahama T; Inouye Y
Forensic Sci Int; 2005 Mar; 148(2-3):131-7. PubMed ID: 15639607
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of methamphetamine, amphetamine and p-hydroxymethamphetamine by rat-liver microsomal preparations in vitro.
Yamamoto T; Takano R; Egashira T; Yamanaka Y
Xenobiotica; 1984 Nov; 14(11):867-75. PubMed ID: 6506759
[TBL] [Abstract][Full Text] [Related]
5. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
6. Properties of the melanin binding of p-bromo-methylamphetamine (V-111).
Báthory G; Szökö E; Magyar K; Deutsch T
Pol J Pharmacol Pharm; 1990; 42(1):19-27. PubMed ID: 2281018
[TBL] [Abstract][Full Text] [Related]
7. NTP Toxicity Studies of beta-Bromo-beta-Nitrostyrene (CAS No. 7166-19-0) Administered by Gavage to F344/N Rats and B6C3F1 Mice.
Toxic Rep Ser; 1994 Aug; 40():1-E30. PubMed ID: 11965239
[TBL] [Abstract][Full Text] [Related]
8. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
[TBL] [Abstract][Full Text] [Related]
9. Effects of alpha-carbon substituents on the N-demethylation of N-methyl-2-phenethylamines by rat liver microsomes.
Duncan JD; Hallström G; Paulsen-Sörman U; Lindeke B; Cho AK
Drug Metab Dispos; 1983; 11(1):15-20. PubMed ID: 6132789
[TBL] [Abstract][Full Text] [Related]
10. Absorption, distribution and elimination of azidomorphine and related substances.
Knoll J; Magyar K; Zólyomi G
Acta Physiol Acad Sci Hung; 1975; 46(2):163-72. PubMed ID: 1235233
[TBL] [Abstract][Full Text] [Related]
11. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
12. Disposition of remoxipride in different species. Species differences in metabolism.
Widman M; Nilsson LB; Bryske B; Lundström J
Arzneimittelforschung; 1993 Mar; 43(3):287-97. PubMed ID: 8489555
[TBL] [Abstract][Full Text] [Related]
13. Incorporation and retention of radiolabeled S-(+)-and R-(-)-methamphetamine and S(+)- and R(-)-N-(n-butyl)-amphetamine in mouse hair after systemic administration.
Stout PR; Claffey DJ; Ruth JA
Drug Metab Dispos; 2000 Mar; 28(3):286-91. PubMed ID: 10681372
[TBL] [Abstract][Full Text] [Related]
14. Absorption, disposition kinetics, and metabolic pathways of cyclohexene oxide in the male Fischer 344 rat and female B6C3F1 mouse.
Sauer JM; Bao J; Smith RL; McClure TD; Mayersohn M; Pillai U; Cunningham ML; Sipes IG
Drug Metab Dispos; 1997 Mar; 25(3):371-8. PubMed ID: 9172957
[TBL] [Abstract][Full Text] [Related]
15. Lauramide diethanolamine absorption, metabolism, and disposition in rats and mice after oral, intravenous, and dermal administration.
Mathews JM; deCosta K; Thomas BF
Drug Metab Dispos; 1996 Jul; 24(7):702-10. PubMed ID: 8818565
[TBL] [Abstract][Full Text] [Related]
16. Absorption and disposition of [14C]-molsidomine in laboratory animals.
Fromson JM; Illing HP; Ings RM; Johnson KI; Johnson P; Ostrowski J; Schraven E; Steward A
Arzneimittelforschung; 1981; 31(2):337-45. PubMed ID: 6894378
[TBL] [Abstract][Full Text] [Related]
17. NTP Technical Report on the metabolism, toxicity and predicted carcinogenicity of diazoaminobenzene (CAS No. 136-35-6).
Ress NB;
Toxic Rep Ser; 2002 Sep; (73):1-23, A1-C6. PubMed ID: 12370695
[TBL] [Abstract][Full Text] [Related]
18. Increased analgesia and alterations in distribution and metabolism of methadone by desipramine in the rat.
Liu SJ; Wang RI
J Pharmacol Exp Ther; 1975 Oct; 195(1):94-104. PubMed ID: 1181409
[TBL] [Abstract][Full Text] [Related]
19. Distribution of S-adenosyl-L-(methyl-14C)methionine in animals.
Placidi GF; Stramentionoli G; Pezzoli C; Cassano GB
Arzneimittelforschung; 1977; 27(9):1680-4. PubMed ID: 579137
[TBL] [Abstract][Full Text] [Related]
20. [Investigations of pharmacokinetics and metabolic behavior of N-L-pnenylalanyl-L-2-amino-1-phenylpropane (author's transl)].
Beck D; Hölzl J; Schönenberger H
Arzneimittelforschung; 1981; 31(10):1726-31. PubMed ID: 7198450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
